These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 6777285

  • 1. The thyroid-stimulating antibody of Graves' disease: evidence for restricted heterogeneity.
    Zakarija M.
    Horm Res; 1980; 13(1):1-15. PubMed ID: 6777285
    [Abstract] [Full Text] [Related]

  • 2. Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity.
    Zakarija M.
    J Clin Lab Immunol; 1983 Feb; 10(2):77-85. PubMed ID: 6133001
    [Abstract] [Full Text] [Related]

  • 3. Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.
    Zakarija M, Jin S, McKenzie JM.
    J Clin Invest; 1988 Mar; 81(3):879-84. PubMed ID: 2893811
    [Abstract] [Full Text] [Related]

  • 4. Thyroid-stimulating autoantibodies usually contain only lambda-light chains: evidence for the "forbidden clone" theory.
    Knight J, Laing P, Knight A, Adams D, Ling N.
    J Clin Endocrinol Metab; 1986 Feb; 62(2):342-7. PubMed ID: 2867105
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
    Marcocci C, Vitti P, Lopez G, Santini F, Mammoli C, Fenzi GF, Pinchera A.
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
    [Abstract] [Full Text] [Related]

  • 7. IgG thyrotrophin receptor antibody activity in Graves' disease; a study of TSH agonist and antagonist activities by isoelectric focusing.
    Creagh FM, Howells RD, Williams S, Didcote S, Hashim FA, Petersen VB, Rees Smith B.
    Clin Endocrinol (Oxf); 1986 Jan; 24(1):79-88. PubMed ID: 3011318
    [Abstract] [Full Text] [Related]

  • 8. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thyroid-stimulating antibody activity between different immunoglobulin G subclasses.
    Weetman AP, Yateman ME, Ealey PA, Black CM, Reimer CB, Williams RC, Shine B, Marshall NJ.
    J Clin Invest; 1990 Sep; 86(3):723-7. PubMed ID: 2168443
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel hypothesis for the etiology of Graves' disease: TSAb may be thyroid stimulating animal IgG-like hormone and TBAb may be the precursor of TSAb.
    Ochi Y, Kajita Y, Hachiya T, Hamaoki M.
    Med Hypotheses; 2012 Jun; 78(6):781-6. PubMed ID: 22472575
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease.
    Zakarija M, McKenzie JM, Munro DS.
    J Clin Invest; 1983 Oct; 72(4):1352-6. PubMed ID: 6138363
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.